Detalles de la búsqueda
1.
Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-944462
2.
The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-451855
3.
Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-443609
4.
Identification of a conserved neutralizing epitope present on spike proteins from highly pathogenic coronaviruses
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428824
5.
Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-125484
6.
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with a unique genetic signature and structural mode of spike recognition
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-444004
7.
Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-438849
8.
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-435528
9.
Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270253
10.
Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21263758
11.
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-096511
12.
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-430696
13.
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-318972
Resultados
1 -
13
de 13
1
Próxima >
>>